Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/REGN
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Regeneron Pharmaceuticals Inc (REGN) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Regeneron Pharmaceuticals (REGN) trades at $769.00, up 3.01% with a bullish technical signal, supported by strong earnings beats and a recent $8 billion immunology alliance expansion with Sanofi. The stock exhibits robust fundamentals, including a 27.86% net income margin and a P/E ratio of 18.88, while analyst consensus is a Buy with a $849.84 price target. Cash flow improved significantly in 2025, with net cash flow turning positive at $634.70 million.
Outlook remains positive driven by pipeline advancements and strategic collaborations, but risks include competitive pressures in ophthalmology and reliance on key products. The stock offers growth potential from new immunology assets, though investors should monitor execution on clinical trials and market share dynamics.
Read full analysis

Key Stats

  • Market Cap
    $78.54B
  • Volume
    618,142
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $557.73
  • Typical Hold Time
    107 Days
  • Enterprise Value
    $73.25B
  • Div Yield
    0.49%
  • Trading Activity
    0% Sell | 100% Buy
$752.77
52W Low: $557.73
13 Oct 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $557.73 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Most Recent News

Content is generated by Aura AI

BioNTech's BNT113 cancer trial misses first endpoint but continues to assess overall survival.

BioNTech's experimental cancer treatment BNT113, combined with pembrolizumab, failed to show a significant improvement in progression-free survival in its Phase 2/3 AHEAD-MERIT trial. Despite missing this first primary endpoint, the trial will procee...

Market News
1 hour ago
Tony Dante
Bearish
news icon
BioNTech's BNT113 cancer trial misses first endpoint but continues to assess overall survival.

Latin American professionals earn 66% more working for U.S. clients, led by Brazilians at $5,329/month.

A survey by Higlobe reveals Latin American professionals working for U.S. clients earn on average 66% more than those working locally, with Brazilians leading at $5,329 per month. The study highlights the importance of technical skills, especially in...

Market News
1 hour ago
Not Specified
Neutral
Latin American professionals earn 66% more working for U.S. clients, led by Brazilians at $5,329/month.

Sea Limited's Chief Compliance Officer sells shares amid key financial ratio insights.

Sea Limited's Chief Compliance Officer, Wang Yanjun, has sold multiple shares recently, including 312 shares on October 12, 2026, totaling nearly $30,000. These sales follow earlier transactions amounting to over $300,000. The company currently has a...

Market News
2 hours ago
Andrew Wynn
Neutral
Sea Limited's Chief Compliance Officer sells shares amid key financial ratio insights.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $78.54B
  • Volume
    618,142
  • Sector
    Health
  • 52W High
    $852.03
  • 52W Low
    $557.73
  • Typical Hold Time
    107 Days
  • Enterprise Value
    $73.25B
  • Div Yield
    0.49%
  • Trading Activity
    0% Sell | 100% Buy
$752.77
52W Low: $557.73
13 Oct 2025
52W High: $852.03
02 Sep 2026

Track Regeneron Pharmaceuticals Inc (REGN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Regeneron Pharmaceuticals Inc has traded between a low of $557.73 and a high of $852.03, highlighting its annual price range. Buy and sell Regeneron Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!